
Dasatinib in the treatment of imatinib refractory chronic myeloid leukemia
Author(s) -
Charles A. Schiffer
Publication year - 2009
Publication title -
biologics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.948
H-Index - 38
eISSN - 1177-5491
pISSN - 1177-5475
DOI - 10.2147/btt.2009.3112
Subject(s) - dasatinib , imatinib , medicine , tyrosine kinase inhibitor , myeloid leukemia , bosutinib , tyrosine kinase , nilotinib , oncology , chronic myelogenous leukemia , imatinib mesylate , cancer research , pharmacology , leukemia , cancer , receptor